Literature DB >> 17054579

Non-erosive reflux disease, functional heartburn and gastroesophageal reflux disease; insights into pathophysiology and clinical presentation.

Eamonn M M Quigley1.   

Abstract

Non-erosive reflux disease (NERD) has emerged as a real entity in the spectrum of gastroesophageal reflux disease (GERD) and may, indeed, represent the most common manifestation of reflux disease. Recent information indicates NERD can be further subclassified based on the results of pH studies and suggests that functional heartburn needs to be differentiated as that subgroup of patients in which there appears to be no relationship between symptoms, however 'typical' of GERD, and acid exposure. Other aspects of NERD need to be appreciated, including overlap with functional dyspepsia and the potential variations in response to such therapeutic interventions as acid-suppressive therapy and fundoplication. It seems quite possible that our failure to separate functional heartburn from NERD, in general, has contributed, in large measure, to diagnostic difficulties and therapeutic disappointment in GERD. An appreciation of the range of entities, of different etiology and pathology, within NERD will foster the development of effective approaches to the assessment and therapy of this challenging disorder.

Entities:  

Mesh:

Year:  2006        PMID: 17054579     DOI: 10.1111/j.1443-9573.2006.00266.x

Source DB:  PubMed          Journal:  Chin J Dig Dis        ISSN: 1443-9573


  7 in total

Review 1.  Current status of functional gastrointestinal evaluation in clinical practice.

Authors:  Daphne Ang; Kwong Ming Fock; Ngai Moh Law; Tiing Leong Ang
Journal:  Singapore Med J       Date:  2015-02       Impact factor: 1.858

Review 2.  Distinction between patients with non-erosive reflux disease and functional heartburn.

Authors:  Maria Giacchino; Vincenzo Savarino; Edoardo Savarino
Journal:  Ann Gastroenterol       Date:  2013

3.  Randomized clinical trial: effect of the 5-HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment.

Authors:  J Tack; F Zerbib; K Blondeau; S B des Varannes; H Piessevaux; J Borovicka; F Mion; M Fox; A J Bredenoord; H Louis; S Dedrie; M Hoppenbrouwers; A Meulemans; A Rykx; L Thielemans; M Ruth
Journal:  Neurogastroenterol Motil       Date:  2014-12-21       Impact factor: 3.598

4.  Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease.

Authors:  Hiroshi Yamashita; Akihiko Okada; Kohji Naora; Masafumi Hongoh; Yoshikazu Kinoshita
Journal:  Dig Dis Sci       Date:  2018-11-21       Impact factor: 3.199

5.  EsReflux Protocol: Epidemiological Study of Heartburn and Reflux-like Symptoms in Spanish Community Pharmacies.

Authors:  Elsa López-Pintor; María Puig-Moltó; Blanca Lumbreras
Journal:  Int J Environ Res Public Health       Date:  2022-08-09       Impact factor: 4.614

Review 6.  Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders.

Authors:  Nicola de Bortoli; Salvatore Tolone; Marzio Frazzoni; Irene Martinucci; Giulia Sgherri; Eleonora Albano; Linda Ceccarelli; Cristina Stasi; Massimo Bellini; Vincenzo Savarino; Edoardo V Savarino; Santino Marchi
Journal:  Ann Gastroenterol       Date:  2018-09-26

7.  Prospective Single Arm Study on the Effect of Ilaprazole in Patients with Heartburn but No Reflux Esophagitis.

Authors:  In Ji Song; Hyun Ki Kim; Na Keum Lee; Sang Kil Lee
Journal:  Yonsei Med J       Date:  2018-10       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.